What is New in Treatment of Differentiated Thyroid Cancer-What is New in Treatment of Differentiated Thyroid Cancer

Video Transcription

Video Summary

In the video, Dr. Ben Guiliardi discusses what's new in the treatment of differentiated thyroid cancer. He begins by acknowledging that new is a matter of perspective and that thyroid cancer management has been evolving over the past 15 years. He discusses low-risk differentiated thyroid cancer and focuses on practical management strategies for non-specialized endocrinologists. This includes topics such as heme-thyroidectomy, active surveillance, and ablative methods. Dr. Guiliardi emphasizes the importance of risk stratification and refining criteria for low-risk disease. He also discusses the role of radioactive iodine and the need for ongoing research to determine optimal TSH targets in low-risk patients. Regarding active surveillance, he highlights the criteria for ideal and appropriate candidates and the importance of regular follow-up to monitor for progression. He also briefly mentions image-guided ablation as a potential option for select patients. Dr. Guiliardi concludes by briefly discussing advanced disease and the use of systemic therapies for advanced or refractory cases. He emphasizes the importance of early referral to specialists to determine appropriate treatment options for these patients. Overall, the video provides an overview of key topics related to the treatment of differentiated thyroid cancer and highlights the evolving nature of management strategies.

Keywords

treatment

differentiated thyroid cancer

evolving

low-risk

management strategies

active surveillance

ablative methods

risk stratification


EndoCareers \| Contact Us \| Privacy Policy \| Terms of Use	CONNECT WITH US
© 2021 Copyright Endocrine Society. All rights reserved.	2055 L Street NW, Suite 600 \| Washington, DC 20036 202.971.3636 \| 888.363.6274